The bank plans to sell all 2,356,000 shares of Hisamitsu Pharmaceutical Company, Inc. it holds at 6,082 yen per share, recording sale gains of 12,048 million yen. The settlement date is February 27, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"8395","jir_company_name":"Saga Bank, Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-02-20","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/8395-20260220-01.pdf","jir_short_summary":"The bank plans to sell all 2,356,000 shares of Hisamitsu Pharmaceutical Company, Inc. it holds at 6,082 yen per share, recording sale gains of 12,048 million yen. The settlement date is February 27, 2026.","jir_summary":"### Result of Tender Offer Application\nSaga Bank, Ltd. applied to sell all 2,356,000 shares of ordinary stock of Hisamitsu Pharmaceutical Company, Inc. it holds in the tender offer conducted by Taiyo Kosan Co., Ltd., and all shares were purchased. The sale price was 6,082 yen per share, with a total sale amount of 14,329 million yen, and the gain on sale is expected to be 12,048 million yen. The settlement date is February 27, 2026.\n\n### Outlook\nFollowing the completion of this tender offer, the gains on sale of stocks will be recorded in the consolidated financial results for the full fiscal year ending March 2026. The consolidated earnings forecast for the fiscal year ending March 2026 is still under review, including other factors, and will be promptly announced as necessary.","jir_financial_highlights":"Number of Shares Held Before Application: 2,356,000 shares (Unknown)\nNumber of Shares Held After Application: 0 shares (All Shares Sold)\nSale Price (Per Share): 6,082 yen (Unknown)\nTotal Sale Amount: 14,329 million yen (Unknown)\nSale Gains: 12,048 million yen (Unknown)\nSettlement Date: February 27, 2026 (Unknown)","jir_category":"","jir_hashtags":"#SagaBankLtd, #TenderOffer, #JapaneseStocks","jir_key_figures":"Number of Shares Held Before Application: 2,356,000 shares\nSale Price (Per Share): 6,082 yen\nSale Gains: 12,048 million yen","jir_meta_title":"Saga Bank, Ltd. to Sell 2,356,000 Shares of Hisamitsu Pharmaceutical at 6,082 Yen per Share, Recording Sale Gains of 12,048 Million Yen","jir_meta_description":"Saga Bank, Ltd. has applied all held shares of Hisamitsu Pharmaceutical in the tender offer, planning to record total sale proceeds of 14,329 million yen and gains on sale of 12,048 million yen in the fiscal year ending March 2026. The settlement date is February 27, 2026.","jir_og_title":"Saga Bank to Record 12,048 Million Yen Gain on Sale of All Hisamitsu Pharmaceutical Shares","jir_og_description":"Saga Bank sold 2,356,000 shares of Hisamitsu Pharmaceutical at 6,082 yen per share. The gain on sale of 12,048 million yen is expected to be recorded in the fiscal year ending March 2026.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16980,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"tender_offer","footnotes":""},"sector":[],"importance":[],"class_list":["post-30356","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n